Beximco Pharmaceuticals (BXP) News Today GBX 48 +1.50 (+3.23%) As of 03:14 AM Eastern Add Compare Share Share Headlines Stock AnalysisChartCompetitorsHeadlinesBuy This Stock BXP Latest News All Sources Trusted Sources MarketBeat Barchart Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent August 2025 July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 Time Period Beximco Pharmaceuticals (LON:BXP) Reaches New 12-Month High - Should You Buy?August 28 at 6:11 AM | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Shares Pass Above Fifty Day Moving Average - Here's WhyAugust 28 at 4:41 AM | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Reaches New 12-Month High - What's Next?August 19, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Trading 15.4% Higher - Should You Buy?August 7, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Hits New 12-Month High - Time to Buy?August 6, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Sets New 52-Week High - Here's What HappenedJuly 30, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Reaches New 52-Week High - Here's What HappenedJuly 23, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Stock Price Passes Above 50 Day Moving Average - Should You Sell?July 18, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Share Price Crosses Below 50-Day Moving Average - Should You Sell?July 2, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Stock Price Passes Below 50-Day Moving Average - Here's What HappenedJune 24, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Share Price Crosses Above 50-Day Moving Average - Here's WhyJune 14, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Stock Price Crosses Above 50 Day Moving Average - Should You Sell?June 6, 2025 | marketbeat.comBeximco Pharma Denies Corruption Allegations in Vaccine ProcurementMarch 21, 2025 | tipranks.comBeximco Pharma Awaits Court Decision on Board AppointmentsMarch 6, 2025 | tipranks.comBeximco Pharmaceuticals Faces Board Restructuring Amid Legal ProceedingsMarch 6, 2025 | tipranks.comBeximco Pharmaceuticals (LON:BXP) Shares Cross Above 50 Day Moving Average - What's Next?February 21, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Stock Crosses Above Fifty Day Moving Average - What's Next?February 12, 2025 | marketbeat.comBangladeshi Government to Permanently Close a Dozen Beximco Apparel FactoriesJanuary 31, 2025 | msn.comBeximco Pharmaceuticals Declares 40% Cash Dividend for 2024January 30, 2025 | tipranks.comBeximco Pharmaceuticals (LON:BXP) Share Price Passes Above 50-Day Moving Average - Time to Sell?January 24, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Stock Crosses Above Fifty Day Moving Average - Here's What HappenedJanuary 16, 2025 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Shares Pass Above 50-Day Moving Average - Here's What HappenedJanuary 16, 2025 | marketbeat.comBeximco Pharma’s Board Restructuring Challenged in CourtJanuary 14, 2025 | tipranks.comAnnual General Meeting StatementDecember 31, 2024 | lse.co.ukBeximco Withdraws Director From Bangladesh Shipping BoardDecember 26, 2024 | msn.comBeximco Pharmaceuticals (LON:BXP) Stock Price Up 1.4% - Time to Buy?December 6, 2024 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Share Price Crosses Above 50 Day Moving Average - What's Next?November 13, 2024 | marketbeat.comBeximco Pharma Share Chat (BXP)November 4, 2024 | lse.co.ukBeximco Pharmaceuticals (LON:BXP) Share Price Passes Below 200 Day Moving Average - Here's What HappenedOctober 26, 2024 | marketbeat.comForeign Investors Express Interest in Buying Beximco SubsidiariesOctober 22, 2024 | msn.comBeximco Pharmaceuticals (LON:BXP) Stock Price Up 16.4% - Still a Buy?October 18, 2024 | marketbeat.comBXP (NYSE:BXP) Stock Quotes, Forecast and News SummaryOctober 11, 2024 | benzinga.comBeximco Pharmaceuticals (LON:BXP) Stock Price Down 24.2%September 3, 2024 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Hits New 1-Year Low at $26.00September 2, 2024 | marketbeat.comBeximco Pharmaceuticals (LON:BXP) Share Price Crosses Below 200-Day Moving Average of $38.05August 30, 2024 | marketbeat.comMid-Year 2024 Review +10.5% / 9.3%; A Few New Ideas...July 31, 2024 | seekingalpha.comBXP, Inc.: A Well-Covered 6% Yield From A Premier Office REITJuly 19, 2024 | seekingalpha.comBeximco Pharma Share ChatFebruary 15, 2024 | lse.co.ukBeximco Pharmaceuticals Ltd DRDecember 14, 2023 | morningstar.comMBeximco Pharmaceuticals Ltd. (BXPq)November 4, 2023 | investing.comBXP.L - Beximco Pharmaceuticals LimitedJune 9, 2023 | finance.yahoo.comBeximco to produce medicines in Saudi Arabia from next yearMarch 12, 2023 | msn.comBeximco PharmaceuticalsFebruary 11, 2023 | fool.co.ukBeximco Pharmaceuticals Ltd.October 26, 2022 | wsj.comBeximco Pharmaceuticals Ltd (BXPH)September 8, 2022 | investing.comBeximco Pharma Granted Sub-license To Produce Molupiravir - Quick FactsJanuary 20, 2022 | nasdaq.comBeximco Pharma Launches Generic Molnupiravir In Bangladesh To Treat Symptomatic COVID-19November 9, 2021 | nasdaq.comBeximco Pharmaceuticals Ltd. GDRAugust 1, 2021 | barrons.com Get Beximco Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for BXP and its competitors with MarketBeat's FREE daily newsletter. Subscribe Now View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. BXP Media Mentions By Week BXP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. BXP News Sentiment▼0.491.03▲Average Medical News Sentiment BXP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. BXP Articles This Week▼20▲BXP Articles Average Week Get the Latest News and Ratings for BXP and Related Stocks Enter your email address to receive the latest news and analysts' ratings for Beximco Pharmaceuticals and its competitors. Sign Up View SMS TermsBy entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. Related Companies and Tools Related Companies Ashtead Group News Today Land Securities Group News Today Taylor Wimpey News Today Safestore News Today EVRAZ News Today Molten Ventures News Today Prs Reit News Today Pinewood Technologies Group News Today AdvancedAdvT News Today Aurora Investment Trust News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (LON:BXP) was last updated on 8/29/2025 by MarketBeat.com Staff From Our PartnersMusk’s Project Colossus could mint millionairesI predict this single breakthrough could make Elon the world’s first trillionaire — and mint more new milliona...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredBONUS GUIDE - Ben Stein Prepares For the Next Financial CrisisWith inflation high, debt soaring, and global tensions rising, a financial storm may be brewing. Economist ...Goldco Precious Metals | SponsoredThis is my Christian duty“This land I will give to you…” — a 4,000-year-old line from Genesis may hold the key to unlocking a $150 tril...Paradigm Press | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredAlex’s “Next Magnificent Seven” stocksThe original “Magnificent Seven” turned $7K into $1.18 million. Now, Alex Green has identified AI’s Next Ma...The Oxford Club | SponsoredElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | Sponsored“Fed Proof” Your Bank Account with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Beximco Pharmaceuticals Limited Please log in to your account or sign up in order to add this asset to your watchlist. Share Beximco Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
MarketBeat All Access